首页> 外文OA文献 >Update on acute respiratory distress syndrome’s pathology. Recent insights into in vivo alveolar regeneration
【2h】

Update on acute respiratory distress syndrome’s pathology. Recent insights into in vivo alveolar regeneration

机译:急性呼吸窘迫综合征病理学的最新进展。最近对体内肺泡再生的见解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute Respiratory Distress Syndrome (ARDS) is a type of acute lung injury characterized on histology by a pattern of Diffuse Alveolar Damage(DAD). Since patients who survive their critical illness generally recover a normal respiratory function, ARDS is regarded as a remarkable example of in vivo alveolar regeneration and mice with udchemical or viral-induced ARDS represent a useful udexperimental model for studying these processes. Recent studies opened new insights into the mechanisms of alveolar regeneration, partly challenging the traditional hypothesis that identifies alveolar type II cells as the progenitor of the alveolar epithelium. Particularly, we proposed Krt14 asuda robust marker of alveolar regeneration and repair, since its expression in the lung parenchyma is only found in pathological conditions during pneumocyte proliferation after severe damage. A better understanding of the processes that regulate in vivo alveolar regeneration would make it possible to revolutionize the therapeutic approachudto patients with respiratory chronic disease, paving the way to the so called “regenerative lung medicine”.
机译:急性呼吸窘迫综合征(ARDS)是一种急性肺损伤,以组织学为特征,表现为弥漫性肺泡损伤(DAD)。由于在危重病中幸存的患者通常可以恢复正常的呼吸功能,因此ARDS被认为是体内肺泡再生的杰出例子,具有化学或病毒诱导的ARDS的小鼠代表了研究这些过程的有用的实验模型。最近的研究为肺泡再生的机制开辟了新的见解,部分挑战了将II型肺泡细胞识别为肺泡上皮祖细胞的传统假设。特别是,我们提出Krt14作为肺泡再生和修复的可靠标志物,因为它在肺实质中的表达仅在严重损伤后的肺细胞增殖过程中的病理条件下发现。更好地了解调节体内肺泡再生的过程,将有可能改变呼吸道慢性病患者的治疗方法,从而为所谓的“再生肺医学”铺平道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号